183 related articles for article (PubMed ID: 29983231)
1. Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition.
Zhu D; Li X; Macrae VE; Simoncini T; Fu X
Trends Endocrinol Metab; 2018 Aug; 29(8):571-580. PubMed ID: 29983231
[TBL] [Abstract][Full Text] [Related]
2. Gaps, limitations and new insights on endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: A narrative review.
El Khoudary SR
Maturitas; 2017 Oct; 104():44-53. PubMed ID: 28923176
[TBL] [Abstract][Full Text] [Related]
3. FSH versus estrogen: who's guilty of breaking bones?
Baron R
Cell Metab; 2006 May; 3(5):302-5. PubMed ID: 16679287
[TBL] [Abstract][Full Text] [Related]
4. A Novel Hypothesis: A Role for Follicle Stimulating Hormone in Abdominal Aortic Aneurysm Development in Postmenopausal Women.
Tedjawirja VN; Nieuwdorp M; Yeung KK; Balm R; de Waard V
Front Endocrinol (Lausanne); 2021; 12():726107. PubMed ID: 34721292
[TBL] [Abstract][Full Text] [Related]
5. Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation.
Wang J; Zhang W; Yu C; Zhang X; Zhang H; Guan Q; Zhao J; Xu J
PLoS One; 2015; 10(8):e0134986. PubMed ID: 26241313
[TBL] [Abstract][Full Text] [Related]
6. The menopausal transition.
Burger HG
Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):347-59. PubMed ID: 8931899
[TBL] [Abstract][Full Text] [Related]
7. New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.
Zaidi M; Blair HC; Iqbal J; Davies TF; Zhu LL; Zallone A; Sun L
Curr Rheumatol Rep; 2009 Jul; 11(3):191-5. PubMed ID: 19604463
[TBL] [Abstract][Full Text] [Related]
8. Follicle-stimulating hormone promotes the transformation of cholesterol to estrogen in mouse adipose tissue.
Cui H; Zhao G; Wen J; Tong W
Biochem Biophys Res Commun; 2018 Jan; 495(3):2331-2337. PubMed ID: 29274780
[TBL] [Abstract][Full Text] [Related]
9. Bone turnover alterations across the menopausal transition in south-eastern Chinese women [corrected].
Ma L; Song Y; Li C; Wang E; Zheng D; Qu F; Zhou J
Climacteric; 2016 Aug; 19(4):400-5. PubMed ID: 27147201
[TBL] [Abstract][Full Text] [Related]
10. [Number of teeth and hormonal profile of postmenopausal women with osteoporosis, osteopenia and normal bone mineral density--a preliminary study].
Stagraczyński M; Kulczyk T; Leszczyński P; Męczekalski B
Pol Merkur Lekarski; 2015 Oct; 39(232):214-8. PubMed ID: 26608487
[TBL] [Abstract][Full Text] [Related]
11. The impact of serum FSH and estradiol on postmenopausal osteoporosis related to time since menopause.
Yoldemir T; Erenus M; Durmusoglu F
Gynecol Endocrinol; 2012 Nov; 28(11):884-8. PubMed ID: 22731753
[TBL] [Abstract][Full Text] [Related]
12. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
13. Follicle-stimulating hormone accelerates osteoclast migration by enhancing methyltransferase-like 3-mediated m6A methylation of cathepsin K.
Li X; Fan C; Wang J; Li P; Xu X; Guo R; Wei J; Cheng Y; Lin H; Fu X
J Mol Endocrinol; 2024 Apr; 72(3):. PubMed ID: 38261314
[TBL] [Abstract][Full Text] [Related]
14. Emerging concepts in the epidemiology, pathophysiology, and clinical care of osteoporosis across the menopausal transition.
Lizneva D; Yuen T; Sun L; Kim SM; Atabiekov I; Munshi LB; Epstein S; New M; Zaidi M
Matrix Biol; 2018 Oct; 71-72():70-81. PubMed ID: 29738833
[TBL] [Abstract][Full Text] [Related]
15. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Implications of the Menopause Transition: Endogenous Sex Hormones and Vasomotor Symptoms.
El Khoudary SR; Thurston RC
Obstet Gynecol Clin North Am; 2018 Dec; 45(4):641-661. PubMed ID: 30401548
[TBL] [Abstract][Full Text] [Related]
17. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women.
Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169
[TBL] [Abstract][Full Text] [Related]
18. Serum follicle stimulating hormone is associated with reduced risk of diabetes in postmenopausal women: The Hong Kong osteoporosis study.
Cheung CL; Kung AWC; Tan KCB
Maturitas; 2018 Aug; 114():41-45. PubMed ID: 29907245
[TBL] [Abstract][Full Text] [Related]
19. Cycle and hormone changes during perimenopause: the key role of ovarian function.
Burger HG; Hale GE; Dennerstein L; Robertson DM
Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
[TBL] [Abstract][Full Text] [Related]
20. Association between changes in oestradiol and follicle-stimulating hormone levels during the menopausal transition and risk of diabetes.
Park SK; Harlow SD; Zheng H; Karvonen-Gutierrez C; Thurston RC; Ruppert K; Janssen I; Randolph JF
Diabet Med; 2017 Apr; 34(4):531-538. PubMed ID: 27973745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
